These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21726616)

  • 21. Roll compaction of mannitol: compactability study of crystalline and spray-dried grades.
    Wagner CM; Pein M; Breitkreutz J
    Int J Pharm; 2013 Sep; 453(2):416-22. PubMed ID: 23742975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefits of die-wall instrumentation for research and development in tabletting.
    Doelker E; Massuelle D
    Eur J Pharm Biopharm; 2004 Sep; 58(2):427-44. PubMed ID: 15296965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of granulation and compaction on the particle size of ibuprofen--development of a size analysis method.
    Le VN; Leterme P; Gayot A; Flament MP
    Int J Pharm; 2006 Sep; 321(1-2):72-7. PubMed ID: 16777361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential of carnuba wax in ameliorating brittle fracture during tableting.
    Uhumwangho MU; Okor RS; Adogah JT
    Pak J Pharm Sci; 2009 Jan; 22(1):58-61. PubMed ID: 19168422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal coating via spray drying to improve powder tabletability.
    Vanhoorne V; Peeters E; Van Snick B; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2014 Nov; 88(3):939-44. PubMed ID: 25445306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding die fill variation during mini-tablet production.
    Goh HP; Heng PWS; Liew CV
    Int J Pharm; 2017 Dec; 534(1-2):279-286. PubMed ID: 29074390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs.
    Gonnissen Y; Verhoeven E; Peeters E; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2008 May; 69(1):320-34. PubMed ID: 18248803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of drug substance particle size on the characteristics of granulation manufactured in a high-shear mixer.
    Badawy SI; Lee TJ; Menning MM
    AAPS PharmSciTech; 2000 Nov; 1(4):E33. PubMed ID: 14727898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanical properties and drug release of venlafaxine HCl solid mini matrices prepared by hot-melt extrusion and hot or ambient compression.
    Avgerinos T; Kantiranis N; Panagopoulou A; Malamataris S; Kachrimanis K; Nikolakakis I
    Drug Dev Ind Pharm; 2018 Feb; 44(2):338-348. PubMed ID: 29023145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advantages of celecoxib nanosuspension formulation and transformation into tablets.
    Dolenc A; Kristl J; Baumgartner S; Planinsek O
    Int J Pharm; 2009 Jul; 376(1-2):204-12. PubMed ID: 19426794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets.
    Kokott M; Lura A; Breitkreutz J; Wiedey R
    Eur J Pharm Biopharm; 2021 Nov; 168():122-130. PubMed ID: 34474110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orally disintegrating mini-tablets (ODMTs)--a novel solid oral dosage form for paediatric use.
    Stoltenberg I; Breitkreutz J
    Eur J Pharm Biopharm; 2011 Aug; 78(3):462-9. PubMed ID: 21324357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process.
    Gonnissen Y; Gonçalves SI; De Geest BG; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2008 Mar; 68(3):760-70. PubMed ID: 17964129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the compaction process and the properties of tablets made of a new co-processed starch excipient.
    Mužíková J; Eimerová I
    Drug Dev Ind Pharm; 2011 May; 37(5):576-82. PubMed ID: 21469946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative measurements of localized density variations in cylindrical tablets using X-ray microtomography.
    Busignies V; Leclerc B; Porion P; Evesque P; Couarraze G; Tchoreloff P
    Eur J Pharm Biopharm; 2006 Aug; 64(1):38-50. PubMed ID: 16621489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous manufacturing of extended release tablets via powder mixing and direct compression.
    Ervasti T; Simonaho SP; Ketolainen J; Forsberg P; Fransson M; Wikström H; Folestad S; Lakio S; Tajarobi P; Abrahmsén-Alami S
    Int J Pharm; 2015 Nov; 495(1):290-301. PubMed ID: 26320548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A quality by design approach to investigate the effect of mannitol and dicalcium phosphate qualities on roll compaction.
    Souihi N; Dumarey M; Wikström H; Tajarobi P; Fransson M; Svensson O; Josefson M; Trygg J
    Int J Pharm; 2013 Apr; 447(1-2):47-61. PubMed ID: 23434544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction.
    Chansanroj K; Betz G
    Acta Biomater; 2010 Aug; 6(8):3101-9. PubMed ID: 20132913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.